Trevi Therapeutics, Inc. (TRVI)
NASDAQ·Healthcare·Biotechnology
$14.44
+7.24%
Mkt Cap $1.90B
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (7 analysts)
$19.25
Range $16.00 – $24.00
Implied Upside
+33.3%
Consensus $19.25 vs current $14.44
NASDAQ·Healthcare·Biotechnology
$14.44
+7.24%
Mkt Cap $1.90B
Buy
13
Hold
0
Sell
0
Price Target (7 analysts)
$19.25
Range $16.00 – $24.00
+33.3%
Consensus $19.25 vs current $14.44